UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002154
Receipt No. R000002629
Scientific Title Randomized phase II study comparing 2nd line therapy for gemcitabine-refractry advanced pancreatic cancer.
Date of disclosure of the study information 2009/07/02
Last modified on 2017/05/16 19:12:43

No. Disposal Last modified on Item of update
1 Insert 2009/07/02 09:32:11
2 Update 2010/01/04 11:31:23 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
3 Update 2011/01/03 16:26:17 Date trial data considered complete
Date analysis concluded
Publication of results
4 Update 2011/07/02 09:31:49 Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2012/07/03 09:24:40 Recruitment status
6 Update 2017/05/16 19:12:43 TEL
Email
Name of primary sponsor
Organization


Contact us.